Allergy & Asthma Network Mothers of Asthmatics (AANMA)

Twice-Daily Dulera® Now Available

Published August - 30 - 2010 Print This Post

DuleraThe Food and Drug Administration (FDA) has approved Dulera®  (mometasone furoate and formoterol fumarate dehydrate) Inhalation Aerosol (Merck & Co.) for patients 12 years and older. Dulera combines an inhaled corticosteroid with a long-acting bronchodilator. It is available in a metered-dose inhaler with a dose counter. Dulera is not indicated for the relief of acute bronchospasm.


First published Allergy & Asthma Today, Fall 2010, Volume 8, Issue 3

For AANMA’s complete chart of asthma medications, click here.